Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting.
Attardi E, Savi A, Borsellino B, Piciocchi A, Cipriani M, Ottone T, Fabiani E, Divona M, Travaglini S, Pascale MR, Awada H, Durmaz A, Visconte V, Della Porta MG, Venditti A, Maciejewski JP, Gurnari C, Voso MT. Attardi E, et al. Among authors: awada h. Blood Adv. 2023 Sep 12;7(17):5122-5131. doi: 10.1182/bloodadvances.2023010173. Blood Adv. 2023. PMID: 37327116 Free PMC article.
Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M.
Gurnari C, Gagelmann N, Badbaran A, Awada H, Dima D, Pagliuca S, D'Aveni-Piney M, Attardi E, Voso MT, Cerretti R, Wolschke C, Rubio MT, Maciejewski JP, Kröger N. Gurnari C, et al. Among authors: awada h. Leukemia. 2023 Mar;37(3):717-719. doi: 10.1038/s41375-023-01820-4. Epub 2023 Jan 28. Leukemia. 2023. PMID: 36709353 No abstract available.
A multimodal analysis of genomic and RNA splicing features in myeloid malignancies.
Durmaz A, Gurnari C, Hershberger CE, Pagliuca S, Daniels N, Awada H, Awada H, Adema V, Mori M, Ponvilawan B, Kubota Y, Kewan T, Bahaj WS, Barnard J, Scott J, Padgett RA, Haferlach T, Maciejewski JP, Visconte V. Durmaz A, et al. Among authors: awada h. iScience. 2023 Feb 18;26(3):106238. doi: 10.1016/j.isci.2023.106238. eCollection 2023 Mar 17. iScience. 2023. PMID: 36926651 Free PMC article.
Novel Scheme for Defining the Clinical Implications of TP53 Mutations in Myeloid Neoplasia.
Bahaj W, Kewan T, Gurnari C, Durmaz A, Ponvilawan B, Pandit I, Kubota Y, Ogbue OD, Zawit M, Madanat Y, Bat T, Balasubramanian SK, Awada H, Ahmed R, Mori M, Meggendorfer M, Haferlach T, Visconte V, Maciejewski JP. Bahaj W, et al. Among authors: awada h. Res Sq [Preprint]. 2023 Mar 9:rs.3.rs-2656206. doi: 10.21203/rs.3.rs-2656206/v1. Res Sq. 2023. PMID: 36945617 Free PMC article. Updated. Preprint.
Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia.
Bahaj W, Kewan T, Gurnari C, Durmaz A, Ponvilawan B, Pandit I, Kubota Y, Ogbue OD, Zawit M, Madanat Y, Bat T, Balasubramanian SK, Awada H, Ahmed R, Mori M, Meggendorfer M, Haferlach T, Visconte V, Maciejewski JP. Bahaj W, et al. Among authors: awada h. J Hematol Oncol. 2023 Aug 3;16(1):91. doi: 10.1186/s13045-023-01480-y. J Hematol Oncol. 2023. PMID: 37537667 Free PMC article.
Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043 patient/years analysis.
Gurnari C, Awada H, Pagliuca S, Dima D, Ullah F, Kawashima N, Kubota Y, Colak C, Visconte V, Patel BJ, Dhillon V, Marneni N, Balasubramanian SK, Kishtagari A, Bat T, Maciejewski JP. Gurnari C, et al. Among authors: awada h. Blood. 2024 Mar 21:blood.2024023988. doi: 10.1182/blood.2024023988. Online ahead of print. Blood. 2024. PMID: 38513233
Thrombocytosis and megakaryocyte changes associated with PRCA.
Abdallah J, Williams RG, Awada H, Raman G, Ozcan YM, Orland MD, Mete M, Chen W, Gurnari C, Maciejewski JP, Bat T. Abdallah J, et al. Among authors: awada h. Blood Adv. 2024 Apr 2:bloodadvances.2023012309. doi: 10.1182/bloodadvances.2023012309. Online ahead of print. Blood Adv. 2024. PMID: 38564765 No abstract available.
150 results